Geneos Therapeutics
PrivateLast Round
Series A
Extension
Sep 27, 2023
Total Funding Raised
$49.5M
Momentum Score
25 /100
Company Overview
Geneos Therapeutics is a biotechnology company that develops DNA-based personalized immunotherapies for cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
personalized cancer vaccineDNA vaccineneoantigen vaccineimmunotherapy platformcancer immunotherapyT-cell responseelectroporation deliveryDNA plasmidclinical-stage biotechhepatocellular carcinomaHCCglioblastomaGBMCDMO partnership
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Geneos Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Geneos Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Sep 27, 2023 | ||||
| Series A Extension | Apr 12, 2023 | ||||
| Series A Extension | Mar 24, 2022 | ||||
| Series A | Mar 3, 2021 | ||||
| Series A | Feb 21, 2019 |
Geneos Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shanghai Healthcare Capital | Series A Extension |
| 3B FUTURE Health Fund | Series A Extension |
| Flerie Invest | Series A Extension |
| Santé Ventures | Series A, Series A Extension |
| Korea Investment Partners | Series A Extension, Series A |
Geneos Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Geneos Therapeutics's valuation, stock price, and market status.
Firmographic Details
HeadquartersPhiladelphia, Pennsylvania
Employee Range12
Year Founded2016
Last FundingSep 27, 2023
